Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has appointed Priya Chaturvedi, Ph.D., as vice president, Global Clinical Quality Assurance. Dr. Chaturvedi will be responsible for developing, implementing and monitoring global policies and procedures to assure worldwide compliance with good clinical practices (GCP) and the laws and regulations governing drug development. Prior to joining Eisai, Dr. Chaturvedi served as executive director, Clinical Quality Assurance, head of...